betaxolol

(redirected from Betoptic)
Also found in: Dictionary.
Related to Betoptic: Timoptic, Bleph-10

betaxolol

 [ba-tak´so-lol]
a cardioselective beta-adrenergic blocking agent, used in the form of the hydrochloride salt; administered orally in treatment of hypertension and topically to the conjunctiva in treatment of glaucoma and ocular hypertension.

betaxolol

/be·tax·o·lol/ (ba-tak´so-lol) a cardioselective β, used in the form of the hydrochloride salt as an antihypertensive and in the treatment of glaucoma and ocular hypertension.

betaxolol

(bā-tăk′sə-lôl′, -lōl′, bē-)
n.
A beta-blocker drug, C18H29NO3, used in its hydrochloride form to treat hypertension and glaucoma.

betaxolol

A selective beta1-receptor blocker used to manage hypertension and glaucoma, possibly by reducing production of aqueous humour.

betaxolol

Cardiology A β-blocker used to treat HTN and glaucoma. See β-blocker.

betaxolol

A BETA-BLOCKER drug used in the treatment of high blood pressure (HYPERTENSION) and, in the form of eyedrops, GLAUCOMA. Brand names are Kerlone and Betoptic.

betaxolol

a topical sympatholytic agent used to reduce intraocular pressure in the treatment of glaucoma.
References in periodicals archive ?
Fourth quarter 2002 sales of all other glaucoma products, including Betoptic S(R) ophthalmic suspension, Azopt(R) ophthalmic suspension and timolol GFS were $70.
Among pharmacologically-treated patients, two-thirds are currently prescribed prostaglandin analogs, specifically Allergan's Lumigan, Alcon's Travatan Z, and Pfizer's Xalatan, with the remaining use being split between fixed combination products (Allergan's Combigan), beta blockers (Alcon's Betoptic S), alpha agonists (Allergan's Alphagan P), and carbonic anhydrase inhibitors (Alcon's Azopt).
Pediatric patent extensions were granted to Alcon for Betoptic S([R]) ophthalmic suspension and to Falcon Pharmaceuticals for Timolol GFS, which extends the patent life of both products by six months.